This seminar series is a perfect place to meet and interact with other young scientists. We anticipate lively and interesting discussion also this time. We are looking forward to the keynote lecture by CCBIO researcher Harsh Dongre,who will talk about how to make the jump of academic independence and establish your own research group.
The program spans several exiting topics including small molecule drug discovery in prostate cancer, PDX models as preclinical tools for investigating myelodysplastic syndromes (MDS), mitochondrial trafficking in the tumor microenvironment and the role of CEL in pancreatic disease. Join us for a perfect occasion for professional input and networking!
Please register within January 30th at 11.00 if you want the FREE LUNCH which is included. If you don’t need the lunch, you can also register later.
- When: Thursday February 2, 2023, 09:00-13:00
- Where: Auditorium B301, Sentralblokka, Haukeland University Hospital, 3rd floor.
- Who: Mostly intended for PhD students and other young researchers, but open for all, and senior scientists are very welcome.
- Registration: Use this link (also even if you have registered for CCBIO901 in Studentweb.) There is no charge.
- General information: More information about the Junior Scientist Symposia can be found here.
- ECTS: Part of CCBIO901, with 3 credits (participation in the program through 2 terms.) All are however welcome for non-ECTS drop-in on each individual symposium.
Program 09.00-09.15: Introduction 09.15-10.00: “My insights on making the jump: transitioning to academic independence?” Keynote lecture by Harsh Dongre 10.00-10.20: Coffee break 10.20-10.45: “Drug discovery of small molecules against prostate cancer” by Yaping Hua 10.45-11.10: “Patient-derived xenograft (PDX) models as preclinical tool for investigation of myelodysplastic syndromes (MDS)” by Angela Sofia Geros Mesquita 11.10-12:00 Lunch (free of charge, register within January 30 at 11.00) 12:00-12:25: “Mitochondria transfer from the microenvironment promotes oxidative metabolism and invasion of glioblastoma” by Shannon Moreino 12.25-12:50: “The role of CEL in pancreatic disease“ by Ranveig Seim Brekke 12:50-13:00: Concluding remarks
Any questions can be addressed to chairs Mari or Vladan
